Online Cognitive Behavioural Therapy for Postpartum Depression
(postnataIiCBT Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does exclude those who have started new medication for depression or anxiety within the last 8 weeks. It also excludes those currently using benzodiazepines.
What data supports the effectiveness of the treatment for postpartum depression?
Research shows that internet-delivered cognitive behavioral therapy (iCBT) can help reduce symptoms of postpartum depression and anxiety. In one study, a mother who used therapist-assisted iCBT reported symptom reduction and high satisfaction with the treatment. Another study found that an online one-day workshop based on cognitive behavioral therapy improved postpartum depression and anxiety.12345
Is online cognitive behavioral therapy safe for postpartum depression?
Research on online cognitive behavioral therapy (iCBT) for postpartum depression shows it is generally safe, with participants reporting satisfaction and a strong connection with their therapists. While specific safety data is limited, the studies suggest no significant safety concerns for this treatment.12356
How is the online cognitive behavioral therapy treatment for postpartum depression different from other treatments?
What is the purpose of this trial?
This research project aims to examine the acceptability and efficacy of a French-Canadian adaptation of a postnatal anxiety and depression program. The main question it aims to answer is:\[1\] When the adapted postnatal Internet-delivered cognitive behavioral therapy (iCBT) is added to treatment as usual (TAU) in community-based care for women with anxiety and depressive symptoms, is the iCBT+TAU condition more effective to reduce symptoms than TAU alone?Participants will:postnatal iCBT group -\> Answer questionnaires before, after (week 6) and 4 weeks after the intervention (week 10); do the 6-week non-guided iCBT program for anxiety and depressive symptoms during the postnatal period.Waitlist, TAU group -\> Answer questionnaires at enrolment, at week 6 and week 10. Participants will have access to the intervention after they complete their last questionnaires.
Research Team
Helen-Maria Vasiliadis, PhD
Principal Investigator
Université de Sherbrooke
Pasquale Roberge, PhD
Principal Investigator
Université de Sherbrooke
Eligibility Criteria
This trial is for postnatal women experiencing mixed anxiety and depressive symptoms. Participants should be comfortable with French-Canadian language as the program is adapted to this variant. There are no specific inclusion or exclusion criteria provided, but typically participants would need access to the internet and have some level of comfort with using online tools.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants in the postnatal iCBT group complete a 6-week non-guided iCBT program for anxiety and depressive symptoms
Follow-up
Participants are monitored for safety and effectiveness after treatment, with questionnaires at week 10
Waitlist Control
Participants in the TAU group complete questionnaires and have delayed access to the iCBT program after the follow-up phase
Treatment Details
Interventions
- Postnatal anxiety and depression iCBT program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Université de Sherbrooke
Lead Sponsor
Centre intégré de santé et services sociaux de la Montérégie-Centre
Collaborator
Centre intégré de santé et services sociaux de la Montérégie-Ouest
Collaborator
Centre intégré de santé et services sociaux de la Montérégie-Est
Collaborator
Champlain Local Health Integration Network
Collaborator
Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator